Dr. Jared Insel, M.D

NPI: 1558369561
Total Payments
$6,648
2021 Payments
$15.21
Companies
29
Transactions
358
Medicare Patients
1,064
Medicare Billing
$60,606

Payment Breakdown by Category

Food & Beverage$6,616 (99.5%)
Education$32.71 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,616 353 99.5%
Education $32.71 5 0.5%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $954.44 64 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $728.33 23 $0 (2020)
Novartis Pharmaceuticals Corporation $650.32 30 $0 (2020)
Amgen Inc. $546.73 23 $0 (2020)
E.R. Squibb & Sons, L.L.C. $545.65 39 $0 (2020)
PFIZER INC. $412.72 23 $0 (2020)
Relypsa, Inc. $291.75 16 $0 (2019)
Regeneron Healthcare Solutions, Inc. $251.77 14 $0 (2019)
Gilead Sciences, Inc. $238.64 13 $0 (2019)
Amarin Pharma Inc. $227.77 14 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2021 $15.21 1 AstraZeneca Pharmaceuticals LP ($15.21)
2020 $228.20 12 Amgen Inc. ($49.54)
2019 $2,149 103 Janssen Pharmaceuticals, Inc ($364.39)
2018 $1,998 107 Boehringer Ingelheim Pharmaceuticals, Inc. ($321.57)
2017 $2,258 135 Janssen Pharmaceuticals, Inc ($311.43)

All Payment Transactions

358 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
04/20/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $15.21 General
Category: Cardiovascular and Metabolism
03/05/2020 Boehringer Ingelheim Pharmaceuticals, Inc. PRADAXA (Drug), JARDIANCE Food and Beverage In-kind items and services $27.24 General
Category: CARDIOVASCULAR
03/04/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $15.38 General
Category: Cardiovascular
02/27/2020 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $18.15 General
Category: Cardiology/Vascular Diseases
02/25/2020 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $15.74 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/20/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $17.46 General
Category: CARDIOVASCULAR
02/18/2020 Amgen Inc. Corlanor (Drug), Repatha Food and Beverage In-kind items and services $19.12 General
Category: Cardiology
02/10/2020 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Food and Beverage In-kind items and services $24.29 General
Category: Genetic Disease
02/05/2020 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $13.70 General
Category: Cardiovascular and Metabolism
01/21/2020 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $30.42 General
Category: Cardiology
01/15/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.31 General
Category: CARDIOVASCULAR
01/14/2020 Boehringer Ingelheim Pharmaceuticals, Inc. PRADAXA (Drug) Food and Beverage In-kind items and services $14.89 General
Category: CARDIOVASCULAR
01/08/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.50 General
Category: Cardiovascular
12/20/2019 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.96 General
Category: Cardiovascular
12/19/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.00 General
Category: Cardiovascular & Metabolism
12/18/2019 Boehringer Ingelheim Pharmaceuticals, Inc. PRADAXA (Drug) Food and Beverage In-kind items and services $21.86 General
Category: CARDIOVASCULAR
12/17/2019 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $22.90 General
Category: Cardiology
12/12/2019 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $15.17 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/11/2019 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $17.27 General
Category: NEUROLOGY
12/06/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $13.42 General
Category: Hypertriglyceridemia
12/04/2019 Regeneron Healthcare Solutions, Inc. PRALUENT (Biological) Food and Beverage In-kind items and services $15.63 General
Category: CARDIOVASCULAR AND METABOLISM
12/03/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.67 General
Category: Cardiovascular & Metabolism
11/28/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $14.58 General
Category: Hypertriglyceridemia
11/15/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $17.26 General
Category: Hypertriglyceridemia
11/12/2019 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $20.64 General
Category: Cardiology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 8 382 468 $70,665 $21,071
2020 11 682 948 $126,785 $39,535
Total Patients
1,064
Total Services
1,416
Medicare Billing
$60,606
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 141 184 $23,184 $10,913 47.1%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 25 25 $22,875 $4,010 17.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 15 16 $3,040 $1,824 60.0%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 34 34 $2,720 $1,354 49.8%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 97 106 $6,890 $1,081 15.7%
93294 Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days Office 2021 30 47 $4,418 $761.21 17.2%
93296 Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days Office 2021 29 45 $4,590 $653.80 14.2%
93015 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report Office 2021 11 11 $2,948 $474.04 16.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 191 272 $34,272 $15,074 44.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 46 58 $11,020 $5,321 48.3%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2020 23 23 $21,045 $3,779 18.0%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 45 46 $5,640 $2,695 47.8%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 178 202 $13,130 $2,648 20.2%
93294 Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days Office 2020 44 116 $10,904 $2,646 24.3%
93296 Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days Office 2020 45 117 $11,934 $2,373 19.9%
93015 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report Office 2020 35 35 $9,380 $1,689 18.0%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 37 41 $3,280 $1,496 45.6%
93280 Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report Office 2020 22 22 $3,828 $996.77 26.0%
93279 Evaluation, testing, and programming adjustment of permanent single lead pacemaker system in one chamber of heart with qualified health care professional analysis, review, and report Office 2020 16 16 $2,352 $816.52 34.7%

About Dr. Jared Insel, M.D

Dr. Jared Insel, M.D is a Cardiovascular Disease healthcare provider based in New Britain, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558369561.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jared Insel, M.D has received a total of $6,648 in payments from pharmaceutical and medical device companies, with $15.21 received in 2021. These payments were reported across 358 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,616).

As a Medicare-enrolled provider, Insel has provided services to 1,064 Medicare beneficiaries, totaling 1,416 services with total Medicare billing of $60,606. Data is available for 2 years (2020–2021), covering 19 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location New Britain, CT
  • Active Since 07/13/2005
  • Last Updated 07/09/2007
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1558369561

Products in Payments

  • XARELTO (Drug) $947.47
  • ENTRESTO (Drug) $650.32
  • ELIQUIS (Drug) $602.29
  • PRADAXA (Drug) $394.88
  • JARDIANCE (Drug) $333.45
  • Veltassa (Drug) $291.75
  • Corlanor (Drug) $289.79
  • Repatha (Biological) $256.94
  • Vascepa (Drug) $227.77
  • CHANTIX (Drug) $216.26
  • BRILINTA (Drug) $209.46
  • BYSTOLIC (Drug) $202.42
  • NORTHERA (Drug) $201.35
  • PRALUENT ALIROCUMAB INJECTION (Biological) $158.96
  • PRALUENT (Drug) $150.12
  • LifeVest (Device) $140.37
  • Advisa (Device) $125.51
  • Ranexa (Drug) $115.75
  • Livalo (Drug) $101.44
  • PRALUENT (Biological) $92.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in New Britain